Filters close
Released: 12-Nov-2018 9:00 AM EST
Italian-American Foundation Honors Antonio Giordano, MD, PhD Founder & President of Sbarro Health Research Organization
Sbarro Health Research Organization (SHRO)

Italian-American Foundation, Filitalia, honors Antonio Giordano, MD, PhD, Founder & President of Sbarro Health Research Organization at Temple University with the Humanitarian award at the foundation’s 31st Anniversary Gala.

   
Released: 13-Oct-2018 2:00 PM EDT
Dompé at the medical conference “The Impact of Environment and Healthy Lifestyles in Human Health” - October 13th, Washington, D.C
Sbarro Health Research Organization (SHRO)

Sbarro Health Research Organization, on the occasion of the medical conference “The impact of environment and healthy lifestyles in human health,” honoured Nathalie Dompé, CEO Dompé Holdings, with a special Award for Societal Impact in Business & Biotechnology, for her work and effort in promoting social responsibility.

Released: 3-Oct-2018 9:00 AM EDT
Medical Conference: The Impact of Environment and Healthy Lifestyles in Human Health
Sbarro Health Research Organization (SHRO)

The medical conference is organized by the Sbarro Health Research Organization (SHRO), in collaboration with Temple University’s College of Science and Technology, the National Italian American Foundation (NIAF), and the Giovan Giacomo Giordano Foundation

Released: 2-Oct-2018 9:00 AM EDT
Healthier Planet, Healthier People, and More Innovative Medical Science with Italian-American Researchers at Annual NIAF Convention
Sbarro Health Research Organization (SHRO)

Foundation Awards Presented for Ethics and Creativity in Medical Research, and Societal Impact in Business & Biotechnology

Released: 24-Aug-2018 1:45 PM EDT
New MicroRNA Target May Inhibit Mesothelioma and Unveils Method to Identify Potential Treatments
Sbarro Health Research Organization (SHRO)

Inhibition of miR-24-3p reduced growth of cancer cells and was found to regulate proteins as a potential treatment target for Mesothelioma (MPM). The new potential target, and the method researchers have used to identify it, is an important step in addressing this challenging disease.

Released: 12-Jun-2018 2:05 PM EDT
Olive Oil Production Threatened by New Deadly Plant Pathogen Recently Introduced to Europe
Sbarro Health Research Organization (SHRO)

One of the iconic ingredients of the Mediterranean diet, which often has been associated with beneficial effects in the prevention of cancer as well as several other disorders, is extra-virgin olive oil. For thousands of years, olive trees were planted on Mediterranean coasts, initially by ancient Greek colonists, followed by several other civilizations and cultures, one generation after the other.

Released: 29-May-2018 3:30 PM EDT
In Debate of Scheduled Versus Spontaneous Exercise, Which Motivates You More?
Sbarro Health Research Organization (SHRO)

Older adults seem to be more motivated by scheduled workouts, including the role of a fitness coach or a significant person involved in their exercise goals, when compared to those getting exercise only through spontaneous physical activity.

   
Released: 2-Apr-2018 9:00 AM EDT
Molecular Inhibitors Can Boost Natural Tumor Suppression to Fight Lung Cancer and Mesothelioma
Sbarro Health Research Organization (SHRO)

Inhibition of the oncogenic kinase AKT, a key protein governing the cell cycle, was found to arrest cancer cell proliferation and triggered their programmed death by apoptosis. The study, published today in Oncogene, represents significant progress in the clinical translation of previous basic scientific discoveries.

Released: 9-Mar-2018 8:55 AM EST
Virtual Reality: An Escape From Painful and Stressful Medical Treatments
Sbarro Health Research Organization (SHRO)

VR has shown promise in several clinical trials assessing its possible utility as a distraction tool to alleviate pain and distress during medical procedures.

Released: 6-Mar-2018 8:55 AM EST
Repurposed Parasite Drug New Weapon Against Mesothelioma
Sbarro Health Research Organization (SHRO)

Anthelmintic drug already approved to treat infections of pinworm parasite was shown to effectively impair both mesothelioma cell growth and migration.

Released: 1-Mar-2018 9:00 AM EST
Diverse Role of CDK9 Gene in Cell Regulation Continues to Reveal Cancer Treatment Targets 25 Years After Discovery
Sbarro Health Research Organization (SHRO)

A gene discovered by Temple University researchers has proved to be an important target for cancer therapy, with the discovery of its roles in controlling cell proliferation, differentiation, apoptosis, and DNA repair.

Released: 17-Jan-2018 4:05 PM EST
Fluctuations of Sex Steroid Hormone Could be Culprit in Age-Related Macular Degeneration
Sbarro Health Research Organization (SHRO)

Gender-based differences may influence several ocular conditions, suggesting that fluctuations in sex steroid homeostasis may have direct effects on eye physiology and the pathogenesis of conditions like Age-Related Macular Degeneration (AMD).

Released: 2-Jan-2018 9:00 AM EST
Detecting Pompe Disease with More Accuracy Key to Urgent Intervention
Sbarro Health Research Organization (SHRO)

Researchers identified a new, more sensitive screening test to recognize Pompe disease, a metabolic disorder affecting cellular processing of glycogen in numerous tissues of the body.

Released: 21-Dec-2017 2:30 PM EST
Xylella: A Conscience, Not a Science Problem
Sbarro Health Research Organization (SHRO)

The Sbarro Health Research Organization congratulates the Italian researchers who were able to prove a direct causal link between the infection by Xylella fastidiosa and the death of olive trees in southern Italy.

Released: 4-Dec-2017 8:55 AM EST
From Medical Discovery to Food and Fine Arts, Italian-American Contributions Celebrated at Annual Foundation Conference
Sbarro Health Research Organization (SHRO)

At this year’s 42nd annual NIAF Gala Weekend at the Washington Marriott Wardman Park Hotel in D.C., all aspects of Italian heritage were celebrated, including food, the fine arts, and scientific discovery. The weekend’s events included the medical conference, “Mediterranean Diet, Human Health and Longevity,” sharing the latest in research into a vital part of Italian culture –– diet and food. Conference presentations explored how the recipes of Italian grandmothers are among the healthiest in the world and can even help fight disease, such as cancer.

   
Released: 27-Nov-2017 9:00 AM EST
New Cancer Therapies Earn Sbarro Health Research Organization President Antonio Giordano 2017 CORE Prize for Oncology
Sbarro Health Research Organization (SHRO)

The CORE Prize for Oncology 2017 was awarded to Professor Antonio Giordano for his groundbreaking discoveries in the field of the cell cycle, which have established an understanding of the fundamental mechanisms at the basis of cancer and the development of a new class of anticancer therapeutics.

Released: 31-Oct-2017 4:05 PM EDT
Italian-American Researchers Present Mediterranean Diet, Health, and Longevity at Annual Medical Conference
Sbarro Health Research Organization (SHRO)

Sbarro Health Research Organization President Antonio Giordano introduces program at National Italian American Foundation 42nd Anniversary Gala Weekend In Washington D.C.

Released: 5-Sep-2017 9:00 AM EDT
Research Reveals Gene Differences in Mouse Model Versus Humans
Sbarro Health Research Organization (SHRO)

Aspects of gene function in humans can be predicted by studies of the corresponding gene in mice, but new research findings have revealed important divergences between the species which scientists will need to understand better through further investigation.

Released: 25-Aug-2017 11:05 AM EDT
Adding Radiation Treatments to Inoperable Lung Cancer Increases Survival by up to One Year
Sbarro Health Research Organization (SHRO)

Patients with unresectable, or inoperable, lung cancer are often given a dismal prognosis, with low rates of survival beyond a few years. Researchers exploring combination therapies have recently discovered improved survival rates by up to one year when patients treated with a newly formulated chemotherapy regimen are also given radiation therapy.



close
0.12929